Home›People›Piotr Bobrowicz
Piotr Bobrowicz

Piotr Bobrowicz

Chief Scientific Advisor and director at Alloy Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 15, 2026·Suggest an edit

About Piotr Bobrowicz

Piotr Bobrowicz is a chief scientific advisor and director at Alloy Therapeutics.

Piotr Bobrowicz first appears on SEC filings in 2021.

Experience

This experience comes from Piotr Bobrowicz's profile and from SEC filings. For roles taken from filings, the years are when the filings name Piotr Bobrowicz in the role, so the role may have started earlier or lasted longer.

Alloy Therapeutics, Inc. Current
Chief Scientific Advisor and director
2020 – Present · Waltham, MA
Drug discovery platforms and development services for biotech companies, pharmaceutical firms and academic researchers.
Compass Therapeutics Inc.
Chief Scientific Officer
2014 – 2019
Adimab
Director of Technology and Platform Development
2008 – 2014
Merck
Group Leader
2006 – 2008
GlycoFi
Senior Scientist
2001 – 2006
Texas A&M University
Postdoctoral Researcher
1998 – 2001

Key Colleagues at Startups

The people Piotr Bobrowicz works with at each company, as listed on that company's latest Form D.

Alloy Therapeutics, Inc. · Form D, Apr 15, 2026
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
UN
JC
Jason Camm
Director
JC
Jason Coloma
Director
AK
Errik Anderson
Errik Anderson
Founder, CEO, Chairman of Alloy
LS
Logan Snyder
Director

Sources

  1. SECAlloy Therapeutics, Inc. Form D, filed Apr 15, 2026